Editorial: Rifampicin.
D000995:Antitubercular Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007918:Leprosy / Q000188:drug therapy; D009164:Mycobacterium Infections / Q000188:drug therapy; D012293:Rifampin / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors; D014376:Tuberculosis / Q000188:drug therapy
D000995:Antitubercular Agents; D012293:Rifampin